AAVCOVID vaccine: A combination of factors harnessing COVID-19
The primary barriers to COVID-19 vaccine development are manufacturing constraints.
Related Articles
WVU Medicine to expand, relocate WVU Eye Institute
The WVU Health System Board of Directors recently approved $233.5 million to fund the construction of a multi-center outpatient facility with additional exam and testing…
Bausch + Lomb announces results from a clinical study of a novel daily nutritional supplement for dry eyes
The company expects to launch the supplement in the US, which features a proprietary blend of ingredients including lutein, zeaxanthin isomers, curcumin and vitamin D3,…
Phoenix-Micron Inc and ArtiKode Intelligence team up to enhance OCT imaging with AI
The collaboration will bring automated, AI-powered OCT segmentation to MICRON Software Suite.
Orbis, FundamentalVR team up to target training
Cataract simulation platform uses virtual reality to train ophthalmologists
Verana Health launches its Qdata Thyroid Eye Disease module
The module encompasses real world data on more than 250,000 de-identified patients and provides information on extracting diagnoses from clinical notes in electronic health records.
Gene editing untangles one strand of the AMD web
CRISPR manipulation presents opportunities and challenges.
Patients with dry eye suffer from worse sleep quality
Analysis showed that patients with dry eye had “worse sleep quality than the healthy population.”
Phoenix-Micron Inc and ArtiKode Intelligence team up to enhance OCT imaging with AI
The collaboration will bring automated, AI-powered OCT segmentation to MICRON Software Suite.
WVU Medicine to expand, relocate WVU Eye Institute
The WVU Health System Board of Directors recently approved $233.5 million to fund the construction of a multi-center outpatient facility with additional exam and testing…